Form 4: Chemours Interim CEO Denise Dignam Reports Transaction Involving Common Stock

Interim CEO of Chemours, Denise Dignam, reports a transaction involving the withholding of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On March 1, 2024, Denise Dignam, Interim CEO of Chemours Co, reported a transaction on Form 4.
• The transaction involved the withholding of 1,299 shares of common stock at a price of $20.78 per share.
• This withholding was to satisfy tax obligations related to the vesting of restricted stock units dividend equivalent units.
• Following the transaction, Dignam beneficially owns 34,229.6299 shares of Chemours Co common stock, including directly owned shares, restricted stock units, and dividend equivalent units.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing related to executive compensation. It doesn't contain any information that would significantly impact investor sentiment positively or negatively. The sentiment is neutral to slightly positive as it reflects ongoing executive compensation practices.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Executive compensation practices, including the use of restricted stock units and dividend equivalent units, are common among publicly traded companies, particularly those in the chemicals industry.
• Companies like Dow, DuPont, and BASF also utilize similar equity-based compensation strategies for their executives.
• The withholding of shares to cover tax obligations is a standard procedure in these compensation plans.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, employees, customers, suppliers, and creditors as it is a routine executive compensation matter.

Key Dates